Sienna Biopharmaceuticals, Inc. (SNNAQ)

USD 0.0

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Total Assets - - - - 107.3 Million 136.84 Million
Total Current Assets - - - - 50.41 Million 77.34 Million
Cash And Short Term Investments - - - - 48.52 Million 74.46 Million
Cash and Cash Equivalents - - - - 48.52 Million 74.46 Million
Short Term Investments - - - - 181 Thousand 181 Thousand
Net Receivables - - - - - -
Inventory - - - - - -
Other Current Assets - - - - 50.41 Million 2.69 Million
Total Non-Current Assets - - - - 56.89 Million 59.5 Million
Net PPE - - - - 311 Thousand 432 Thousand
Good Will And Intangible Assets - - - - 56.58 Million 59.06 Million
Good Will - - - - 10.98 Million 11.47 Million
Intangible Assets - - - - 45.59 Million 47.59 Million
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets - - - - - -
Other Assets - - - - - -
Total Liabilities - - - - 80.72 Million 45.64 Million
Total Current Liabilities - - - - 24.34 Million 8.24 Million
Account Payables - - - - 2.79 Million 2.35 Million
Tax Payables - - - - - -
Short Term Debt - - - - - -
Deferred Revenue - - - - - -
Other Current Liabilities - - - - 21.55 Million 5.88 Million
Total Non Current Liabilities - - - - 56.37 Million 37.4 Million
Long-Term Debt - - - - 30.12 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - - 15.74 Million 26.44 Million
Other Liabilities - - - - - -
Total Equity - - - - 159.36 Million 85.89 Million
Stock Holders Equity - - - - 159.36 Million 85.89 Million
Common Stock - - - - - 2000.00
Retained Earnings - - - - 159.36 Million 85.89 Million
Accumulated other comprehensive income - - - - 3.19 Million 5.37 Million
Common Stock Equity - - - - 159.36 Million 85.89 Million
Capital Lease Obligation - - - - - -
Total Investments - - - - 181 Thousand 181 Thousand
Total Debt - - - - 30.12 Million -
Net Debt - - - - -18.4 Million -74.46 Million

Balance Sheet Charts